Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II crossover dose-ranging study of PSD502 for premature ejaculation
2008-003650-15Phase 2Completed
- Sponsor
- Plethora Solutions
- Start
- Oct 2008
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lidocaine + prilocaine in premature ejaculation (PE) (4 arms), sponsored by Plethora Solutions. Primary endpoint: Change from baseline in mean intra-vaginal ejaculatory latency time (IELT). Started Oct 2008; status: completed.
02
Drugs
lidocaine + prilocaine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on 2008-003650-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003650-15.